{"database": "lobbying", "table": "lobbying_activities", "rows": [[1451177, "4152e43a-7e49-44a2-843f-d5946007b0ad", "Q3", "EVERGREEN ASSOCIATES, LTD.", 13984, "PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION", 2013, "third_quarter", "PHA", "- RIN: 0910-AG18, Electronic Distribution of Content Labeling for Human Prescription Drug and Biological Products\n- Risk Communications: Consumer Medication Information, Medication Guides, Patient Package Inserts, Professional Inserts\n- P.L. 112-144: Food and Drug Administration Safety and Innovation Act: Title XI- Other Provisions, Subtitle C- Miscellaneous Provisions, Sec. 1140- Study on Drug Labeling by Electronic Means- HR 1919: Safeguarding Americas Pharmaceuticals Act of 2013: Section 8- Electronic labeling\n- S 957: Drug Supply Chain Security Act\n- S 959: Pharmaceutical Compounding and Accountability Act\n- H.R. 3204: Drug Quality and Security Act", "Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 10000, null, 0, 0, "2013-10-18T12:28:58.580000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1451177"], "units": {}, "query_ms": 1.0087410337291658, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}